09.02.2013 Views

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BILL & MELINDA GATES FOUNDATION 56-2618866<br />

FORM <strong>990</strong><strong>PF</strong> - GENERAL EXPLANATION ATTACHMENT<br />

SUMMARY OF DIRECT CHARITABLE ACTIVITIES<br />

FORM <strong>990</strong>-<strong>PF</strong>, PART IX-A<br />

1. US PROGRAM - CONDUCTED AND EVALUATED RESEARCH ON ISSUES OF INTEREST TO<br />

THE FIELD OF EDUCATION. ASSISTED ORGANIZATIONS WORKING IN THE AREA OF<br />

EDUCATIONAL IMPROVEMENTS IN ASSESSING PROGRESS ON CURRENT PROJECTS,<br />

CONDUCTING BUSINESS PLANNING, COMMUNICATIONS SUPPORT, TECHNICAL SUPPORT<br />

AND OTHER CONSULTING SERVICES.<br />

TOTAL EXPENDITURES: $55,387,349<br />

2. GLOBAL HEALTH PROGRAM - PRIMARY ACTIVITIES INCLUDED: (1) SUPPORTING<br />

THE LAUNCH OF THE LIVING PROOF PROJECT FOR AN IMPATIENT OPTIMIST<br />

PRESENTATION GIVEN BY BILL AND MELINDA GATES, A GLOBAL HEALTH MEDIA<br />

CAMPAIGN AROUND THE LAUNCH OF LIVING PROOF, AND ADDITIONAL VIDEO CONTENT;<br />

(2) SUPPORT FOR THE FOUNDATION'S GH GRANTEES TO BUILD THE COMMUNICATIONS<br />

CAPACITY OF KEY GRANTEES SO THEY CAN ADVOCATE FOR ISSUES, PROMOTE THEIR<br />

WORK AND SUCCESSES, AND MANAGE COMMUNICATIONS VULNERABILITIES; (3) WORK<br />

TO DEVELOP A MAP OF THE CURRENT STATE OF THE PNEUMOCOCCAL AND ROTAVIRUS<br />

VACCINE INTRODUCTION ACTIVITIES, AS WELL AS IDENTIFYING INTRODUCTION PLAN<br />

OVERLAPS, GAPS, AND RESOURCE CONSTRAINTS, AND DEVELOPING A PLAN TO<br />

OPTIMIZE THE INTRODUCTION OF PNEUMOCOCCAL AND ROTAVIRUS VACCINES; (4)<br />

SUPPORTED BMGF HIV PROGRAM DEVELOPMENT IN CHINA; (5) WORK TO ENSURE THAT<br />

PRODUCT MARKETS WERE READY FOR NEW INTERVENTIONS FOR TB VACCINES, DRUGS,<br />

AND DIAGNOSTICS; (5) A PRODUCT DEVELOPMENT PARTNERSHIP OPTIMIZATION<br />

PROJECT TO DEVELOP A RISK ADJUSTED PORTFOLIO MODEL AND A COST ESTIMATION<br />

TOOL TO DETERMINE THE CLINICAL DEVELOPMENT COSTS FOR THE GLOBAL HEALTH<br />

PIPELINE OVER THE NEXT 10 YEARS.<br />

TOTAL EXPENDITURES: $22,080,583<br />

3. GLOBAL DEVELOPMENT PROGRAM - COMMISSIONED RESEARCH ON NEW HOUSING<br />

FINANCE PRODUCTS FOR THE POOR AND MICRO-FINANCE PROGRAMS AROUND THE<br />

WORLD. COMMISSIONED RESEARCH ON INTEGRATING THE URBAN POOR INTO<br />

COMMUNITY PLANNING AND DEVELOPMENT AROUND THE WORLD. COMMISSIONED<br />

RESEARCH ON FERTILIZER SUPPLY ISSUES IN SUB-SAHARAN AFRICA, DETERMINING<br />

NEEDS OF SMALL HOLDER FARMERS, AND ON AN ASSESSMENT OF ETHIOPIA'S<br />

AGRICULTURAL EXTENSION SYSTEM. CONVENED GRANTEES FROM 15 COUNTRIES TO<br />

EXCHANGE EXPERIENCES AND IDEAS IN ORDER TO IMPROVE PROGRAMS AND<br />

STRENGTHEN THE GRANTEE NETWORK FOR FUTURE COMMUNICATION AND SUPPORT.<br />

COMMISSIONED RESEARCH TO IDENTIFY OPTIMAL OPERATING MODELS FOR DELIVERING<br />

SOCIAL PAYMENTS AND SAVINGS ACCOUNTS FOR MEXICO'S POOREST THROUGH A<br />

NETWORK OF RURAL COMMUNITY STORES. COMMISSIONED RESEARCH ON METHODS TO<br />

IMPROVE THE QUALITY OF LEARNING OUTCOMES IN THE DEVELOPING WORLD.<br />

TOTAL EXPENDITURES: $12,962,604<br />

FOR PUBLIC DISCLOSURE

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!